Altering chromatic aberration: how this latest trend in intraocular-lens design affects visual quality in pseudophakic patients.
Journal Information
Full Title: Eye Vis (Lond)
Abbreviation: Eye Vis (Lond)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe study procedures adhered to the tenets of the Declaration of Helsinki and were conducted in compliance with Ethical Committee's approval (S-392/2011) granted by Heidelberg Medical Faculty's review board. Informed consent was obtained from all participants. Consent for publicationNot applicable. Competing interestsG. U. Auffarth and R. Khoramnia report grants, personal fees, nonfinancial support and consulting fees from Johnson and Johnson Vision Care, Inc. and Alcon Laboratories, Inc., grants, personal fees, and nonfinancial support from Hoya Corp., Kowa Co. Ltd., Oculentis/Teleon, Carl Zeiss Meditec AG, Santen and SIFI, grants and personal fees from Bausch + Lomb, Biotech and OCULUS Optikgeräte GmbH, and grants from AcuFocus, Inc., Eyebright, Hanita, Ophtec, Ophthalmopro, Physiol, Rayner and VSY, outside the submitted work. G. Łabuz, H. Güngör and T. M. Yildirim declare no potential conflict of interest. The University of Heidelberg holds a pending patent application (no. EP22187235) entitled "Lens with extended depth of focus by inducing an excess of longitudinal chromatic aberration," with G.U. Auffarth and G. Łabuz as inventors. Competing interests G. U. Auffarth and R. Khoramnia report grants, personal fees, nonfinancial support and consulting fees from Johnson and Johnson Vision Care, Inc. and Alcon Laboratories, Inc., grants, personal fees, and nonfinancial support from Hoya Corp., Kowa Co. Ltd., Oculentis/Teleon, Carl Zeiss Meditec AG, Santen and SIFI, grants and personal fees from Bausch + Lomb, Biotech and OCULUS Optikgeräte GmbH, and grants from AcuFocus, Inc., Eyebright, Hanita, Ophtec, Ophthalmopro, Physiol, Rayner and VSY, outside the submitted work. G. Łabuz, H. Güngör and T. M. Yildirim declare no potential conflict of interest. The University of Heidelberg holds a pending patent application (no. EP22187235) entitled "Lens with extended depth of focus by inducing an excess of longitudinal chromatic aberration," with G.U. Auffarth and G. Łabuz as inventors."
"Funding Open Access funding enabled and organized by Projekt DEAL. The David J Apple Laboratory receives support from the Klaus Tschira Foundation, Heidelberg, Germany. The funding organizations had no role in the design or conduct of this research or in the preparation of the manuscript."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025